A vs ADM Stock Comparison

Scores Breakdown

Metric	A	ADM
📈 Growth	26/30	26/30
💰 Profitability	17/20	16/20
🏦 Financial Health	15/20	18/20
💵 Valuation	16/20	14/20
⚠️ Risk (lower is better)	5/10	7/10
Overall Score	79/100	77/100

Side-by-Side Summaries

A Analysis	ADM Analysis
📈 Growth & Financial Trajectory Eight quarters show revenue rising from about $1.66B in 2024-Q1 to about $1.84B in 2026-Q2, while Net Income fluctuates but trends higher, with a peak near $434M in 2025-Q4 and a pace around $300–$339M in other quarters. The trend depicts steady top-line growth and durable earnings power despite quarterly volatility. 💰 Margins & Cash Flow Gross Margin remains in the low-to-mid 50s% (roughly 53%), and Operating Margin sits in the low- to mid-20s% (roughly 21%). Cash flow remains broadly positive; Net Cash Flow From Operating Activities ranges in the hundreds of millions per quarter, while investing and financing activities swing, producing occasional negative free cash flow but overall liquidity. 🛡️ Balance Sheet & Liquidity Assets run around $12.8–$13.0B, with long-term debt near $3.0B and equity attributable to parent around $6.1–7.0B. Current assets ($4.2–4.9B) cover current liabilities ($1.9–2.3B), indicating solid liquidity and resilience, despite occasional negative equity readings due to accounting structure. ⚠️ Key Drivers & Risks Drivers: Life sciences instrumentation demand; continued R&D activity driving consumables and systems adoption. Risks: Cyclicality of lab spending; valuation sensitivity and dependence on continued margin stability.	📈 Growth & Financial Trajectory Over the 8 quarters, Revenues progressed from about $21.50B (2024 Q4) to $22.68B (2026 Q2), with a mid-period trough in 2025 Q4 near $18.56B. Net income rose from about $0.42B to roughly $0.91B by 2026 Q2, though 2025 saw a dip before the rebound. The 8-quarter trend shows growth, albeit choppy, culminating in a clear earnings acceleration on a year-over-year basis. 💰 Margins & Cash Flow Gross margin expanded from the mid single digits (roughly 6.4%–7%) to around 9% in 2026 Q1 and roughly 8.5% in 2026 Q2, signaling better product mix and leverage. Operating margin ran in the low-to-mid single digits, reflecting ongoing efficiency gains amid revenue volatility. Operating cash flow remained positive for most quarters; 2026 Q1 shows strong cash from operations, while 2026 Q2 recorded a net cash outflow driven by investing/financing activities. Investing cash flow remained negative as capex/activity persisted. 🛡️ Balance Sheet & Liquidity Assets of about $52–53B supported by equity around $22–23B and liabilities of roughly $29–30B, yielding solid leverage metrics. Current assets > current liabilities in most periods, with a healthy liquidity cushion and modest long-term debt (~$7.6B). ⚠️ Key Drivers & Risks Drivers: Demand in food/agri value chain; favorable margin trajectory from mix improvement and cost discipline. Risks: Commodity/price cycles and cyclicality; potential valuation sensitivity to commodity and macro shifts.

A Analysis

ADM Analysis

📈 Growth & Financial Trajectory

Eight quarters show revenue rising from about $1.66B in 2024-Q1 to about $1.84B in 2026-Q2, while Net Income fluctuates but trends higher, with a peak near $434M in 2025-Q4 and a pace around $300–$339M in other quarters. The trend depicts steady top-line growth and durable earnings power despite quarterly volatility.

💰 Margins & Cash Flow

Gross Margin remains in the low-to-mid 50s% (roughly 53%), and Operating Margin sits in the low- to mid-20s% (roughly 21%). Cash flow remains broadly positive; Net Cash Flow From Operating Activities ranges in the hundreds of millions per quarter, while investing and financing activities swing, producing occasional negative free cash flow but overall liquidity.

🛡️ Balance Sheet & Liquidity

Assets run around $12.8–$13.0B, with long-term debt near $3.0B and equity attributable to parent around $6.1–7.0B. Current assets ($4.2–4.9B) cover current liabilities ($1.9–2.3B), indicating solid liquidity and resilience, despite occasional negative equity readings due to accounting structure.

⚠️ Key Drivers & Risks

Drivers: Life sciences instrumentation demand; continued R&D activity driving consumables and systems adoption.
Risks: Cyclicality of lab spending; valuation sensitivity and dependence on continued margin stability.

📈 Growth & Financial Trajectory

Over the 8 quarters, Revenues progressed from about $21.50B (2024 Q4) to $22.68B (2026 Q2), with a mid-period trough in 2025 Q4 near $18.56B. Net income rose from about $0.42B to roughly $0.91B by 2026 Q2, though 2025 saw a dip before the rebound. The 8-quarter trend shows growth, albeit choppy, culminating in a clear earnings acceleration on a year-over-year basis.

💰 Margins & Cash Flow

Gross margin expanded from the mid single digits (roughly 6.4%–7%) to around 9% in 2026 Q1 and roughly 8.5% in 2026 Q2, signaling better product mix and leverage.
Operating margin ran in the low-to-mid single digits, reflecting ongoing efficiency gains amid revenue volatility.
Operating cash flow remained positive for most quarters; 2026 Q1 shows strong cash from operations, while 2026 Q2 recorded a net cash outflow driven by investing/financing activities. Investing cash flow remained negative as capex/activity persisted.

🛡️ Balance Sheet & Liquidity

Assets of about $52–53B supported by equity around $22–23B and liabilities of roughly $29–30B, yielding solid leverage metrics. Current assets > current liabilities in most periods, with a healthy liquidity cushion and modest long-term debt (~$7.6B).

⚠️ Key Drivers & Risks

Drivers: Demand in food/agri value chain; favorable margin trajectory from mix improvement and cost discipline.
Risks: Commodity/price cycles and cyclicality; potential valuation sensitivity to commodity and macro shifts.

Similar Companies

AMAT Score: 79 AME Score: 78 ANET Score: 85 GOOGL Score: 80 TMO Score: 75 WAT Score: 74

Top Rated Companies

View Top 20 →

TPL "Texas Pacific Land Corp"

MPWR "MONOLITHIC POWER SYSTEMS, INC."

AMD "ADVANCED MICRO DEVICES INC"

KO "COCA COLA CO"

TEL "TE Connectivity plc"